NOUV Prepares To Issue Dividend To PURA Shareholders Today Publishing Current Financial Reports
July 08 2019 - 9:16AM
InvestorsHub NewsWire
NOUV Prepares To Issue Dividend To
PURA Shareholders Today Publishing Current Financial Reports
Dallas, TX -- July 8, 2019 -- InvestorsHub
NewsWire -- Nouveau (USOTC:
NOUV) (“NOUV”) management today announced publishing current
financial reports in preparation of issuing a stock dividend to the
shareholders of Puration, Inc. (USOTC:
PURA) (”PURA”). NOUV and PURA management plan to publish
an update tomorrow following up on the NOUV financials published
today to advise shareholders on the latest news regarding the
coming NOUV dividend stock issuance to PURA
shareholders.
PURA spun off its Texas based cannabis
cultivation operation that concentrates on growing hemp to NOUV
late last year. The spinoff deal includes a dividend of NOUV
stock to be issued to PURA shareholders. Similar to Village Farms in West Texas, a major tomato
farming outfit the produces for H-E-B, Tom Albertsons and Walmart,
NOUV is expanding its conventional Texas based nursery operation
into a major hemp farming operation. The global industrial hemp market is anticipated to
grow from USD 4.6 billion in 2019 to USD 26.6 billion by
2025. PURA and NOUV are making
substantial progress toward the acceleration of the NOUV stock
dividend to be issued to PURA shareholders in conjunction with
PURA’s cannabis cultivation operation. Learn the latest on
the upcoming dividend when PURA and NOUV management publish an
online management update on Tuesday, July 9th,
2019.
NOUV recently published a new
website with the intention of accelerating the planed dividend
of NOUV shares to PURA shareholders in conjunction with PURA's
spinoff of its cannabis cultivation operations to NOUV in the
fourth quarter of last year. The new website is an
alternative disclosure site that includes detailed corporate
information including capital structure, financial disclosures,
management information, stock quotation and more. The new
site includes a research analyst report on the current business
and operations of NOUV and an independent fairness opinion on the value of
the NOUV shares to be issued to PURA shareholders in conjunction
with PURA's spinoff of its cannabis cultivation operation to
NOUV. The new website is designed with the intention of
providing the details on NOUV's operations, structure and value
that can support investment decisions. Management considers
making these basic details available as a prerequisite to issuing
the planed stock dividend. With the NOUV business information
site now live and with the financial
disclosures up to date, management is confident that a prompt
issuance of the dividend of NOUV shares to PURA shareholders will
follow.
PURA Speculative
Buy Recommendation and $0.25 PPS Target w/Potential to
$0.35
Goldman Small Cap Research recently
released a new research report recommending PURA as a
Speculative
BUY with a $0.25 PPS Target. Goldman Small Cap Research further
reports that the shares of PURA “have the potential to reach the
$0.35 mark.” The report highlights PURA’s growing EVERx CBD
Sports Water sales and the coming introduction of new beverages as
well as the potential for the company to exceed its 2019 sales
targets through the pending doubling of its production capacity and
through planned acquisitions. The report further details
recent updates intended to accelerate the issue of Nouveau
(USOTC:
NOUV) stock to PURA shareholders in a dividend
distribution. Notably, the report points to the capacity and
quality improvements enabled by the addition of a new team member
with exceptional beverage industry professional
experience.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc. and Nouveau, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024